Paige receives FDA clearance for the FullFocus viewer for digital pathology

Clean Sweep Live Auction on Wed. Sept. 23rd. Click to see the full inventory

Paige receives FDA clearance for the FullFocus viewer for digital pathology

Press releases may be edited for formatting or style | July 21, 2020 Rad Oncology
NEW YORK--(BUSINESS WIRE)--Paige, a global leader in computational pathology, today announced it received Federal Drug Administration (FDA) 510(k) clearance for the FullFocus™, a digital pathology image viewer for the purpose of primary diagnosis. This 510(k) clearance from the FDA allows in vitro diagnostic (IVD) use of FullFocus with FDA-authorized Philips Ultra Fast Scanner and paves the way for IVD use of FullFocus with additional IVD Whole Slide Imaging (WSI) scanners in the future.

Lack of interoperability, intensive capital requirements and burdensome, on-premise storage have long been a challenge in the adoption of digital pathology. The foundation for the FullFocus viewer was initially created and validated at Memorial Sloan Kettering Cancer Center (MSK) to allow researchers and pathologists to intuitively view and navigate digital images of surgical pathology slides acquired on all major commercial brands of WSI scanners. After refinement based on 18 months of daily use for retrospective slide review by dozens of practicing pathologists at MSK, the viewer was further enhanced by Paige to meet the performance requirements for IVD use, with accurate color reproducibility, optimized viewing speeds and adherence to a certified quality management system. Committed to providing a flexible solution for hospitals, Paige is working to expand upon the clearance to incorporate use with additional WSI scanners and monitor displays in the near future.

“The COVID-19 pandemic has made it painfully clear that pathologists need better solutions to work safely and remotely,” said Leo Grady, PhD CEO at Paige. “Pathology labs, hospitals and biopharma companies need to serve patients and conduct research with little disruption, without having to be physically present at their labs. Receiving FDA clearance for the FullFocus viewer allows Paige to further its commitment to modernizing workflows for pathologists so that they can manage their ever-increasing workloads in an efficient, organized, collaborative and secure way and ultimately help patients get the right care at the right time.”

Midmark® Workstations & Telehealth - Enabling healthcare from anywhere

Midmark Workstations are made to order with customization that can assist with the integration of telehealth and other technology at the point of care, wherever that may be. See more>>>

The FullFocus viewer operates within the Paige Platform, which also offers fully-managed, cost-effective storage capabilities. The combined offering can be quickly deployed in any clinical setting, requires minimal upfront costs and allows for collaboration between geographically distributed pathologists, streamlining the path to digital pathology. The Paige Platform is also designed to deliver best-in-class computational pathology products.

You Must Be Logged In To Post A Comment